BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25014075)

  • 1. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.
    Guerriero E; Simon N; Nelken B; Baldeyrou B; Djobo B; Vasseur M; Allorge D; Décaudin B; Odou P
    Ther Drug Monit; 2014 Aug; 36(4):499-504. PubMed ID: 25014075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay:  Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
    Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
    Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
    Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
    Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
    Mendu DR; Chou PP; Soldin SJ
    Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring methotrexate in clinical samples from cancer patients during chemotherapy with a LSPR-based competitive sensor.
    Zhao SS; Bichelberger MA; Colin DY; Robitaille R; Pelletier JN; Masson JF
    Analyst; 2012 Oct; 137(20):4742-50. PubMed ID: 22943049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
    den Boer E; Koch BC; Huisman R; de Jonge R
    Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
    Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
    Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
    Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
    Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A U-HPLC-ESI-MS/MS-based stable isotope dilution method for the detection and quantitation of methotrexate in plasma.
    den Boer E; Heil SG; van Zelst BD; Meesters RJ; Koch BC; Te Winkel ML; van den Heuvel-Eibrink MM; Luider TM; de Jonge R
    Ther Drug Monit; 2012 Aug; 34(4):432-9. PubMed ID: 22689188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood concentration monitoring during high-dose methotrexate treatment].
    Jiao L; Zhou DB; Wang SJ; Zhang W; Duan MH; Li J; Han B; Xu Y; Zhao YQ; Shen T; Wang Q; Ye M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):564-6. PubMed ID: 19968071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
    Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
    Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of time to clearance of high-dose methotrexate using the ARK immunoassay in pediatric hematology/oncology patients: A single-center experience.
    Kowalski KE; Higgins TA
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28788. PubMed ID: 33164288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miniature multi-channel SPR instrument for methotrexate monitoring in clinical samples.
    Zhao SS; Bukar N; Toulouse JL; Pelechacz D; Robitaille R; Pelletier JN; Masson JF
    Biosens Bioelectron; 2015 Feb; 64():664-70. PubMed ID: 25441416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of methotrexate on the pediatric oncology ward: can blood sampling from central venous accesses substitute for capillary finger punctures?
    Ritzmo C; Albertioni F; Cosic K; Söderhäll S; Eksborg S
    Ther Drug Monit; 2007 Aug; 29(4):447-51. PubMed ID: 17667799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis.
    Inoue S; Hashiguchi M; Kawai S; Mochizuki M
    Yakugaku Zasshi; 2009 Aug; 129(8):1001-5. PubMed ID: 19652507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Drug Monitoring of Methotrexate in Plasma Using Ultra High-Performance Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry: Necessary After Administration of Glucarpidase in Methotrexate Intoxications.
    Mulder MB; Huisman R; Engels FK; van der Sluis IM; Koch BCP
    Ther Drug Monit; 2018 Aug; 40(4):383-385. PubMed ID: 29994985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of methotrexate in cerebrospinal fluid after systemic high-dose infusion in children: can the burden of intrathecal methotrexate be reduced?
    Niemann A; Mühlisch J; Frühwald MC; Gerss J; Hempel G; Boos J
    Ther Drug Monit; 2010 Aug; 32(4):467-75. PubMed ID: 20571463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A device for rapid elevation of plasma methotrexate (MTX) concentration and its maintenance in high-dose MTX therapy].
    Miyauchi Y; Mii Y; Morishita T; Miura S; Honoki K; Aoki M; Kido A; Tamai S; Hino M; Nomura Y; Nakanishi E
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):595-9. PubMed ID: 8678518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPLC-MS/MS Analysis of Methotrexate in Human Plasma and Comparison with the Fluorescence Polarization Immunoassay.
    Mei S; Zhu L; Li X; Wang J; Jiang X; Chen H; Huo J; Yang L; Lin S; Zhao Z
    Anal Sci; 2017; 33(6):665-670. PubMed ID: 28603183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.